BridgeMD
New treatment option for Cannabis Use Disorder
Official title RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
ClinicalTrials.gov ID: NCT07184983
What this study is testing
- What it's testing
- The purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditation practice in otherwise healthy adults seeking to reduce cannabis use in the context of cannabis use disorder (CUD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 to 65
You may be able to join if
- Aged 22-65 years (inclusive)
- Currently meets the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for CUD, as determined by DSM-V criteria (M.I.N.I)
- Positive for cannabis on the 11-COOH-THC single panel urine test
- Seeking treatment to reduce or discontinue cannabis use (Marijuana Ladder ranged between 5-8 [inclusive])
- Kessler Psychological Distress Scale (K10) score \< 35 (minimal to moderate distress)
You likely can't join if
- Cannabis is used exclusively as prescribed or directed by their provider
- Meets DSM-V criteria for substance use disorder within the past six months for any psychoactive substance other than cannabis
- Meets DSM-V criteria for alcohol use disorder within the past six months
- Primary psychiatric disorder (major depressive disorder, bipolar disorder, or psychotic disorder) as the principal diagnosis, independent of cannabis...
- Primary neurologic or major medical disorder that would interfere with study participation.
- Enrolled in group or individual therapy for substance use disorder that would be concurrent with the study intervention
See the full eligibility criteria
- Aged 22-65 years (inclusive)
- Currently meets the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for CUD, as determined by DSM-V criteria (M.I.N.I)
- Positive for cannabis on the 11-COOH-THC single panel urine test
- Seeking treatment to reduce or discontinue cannabis use (Marijuana Ladder ranged between 5-8 [inclusive])
- Kessler Psychological Distress Scale (K10) score \< 35 (minimal to moderate distress)
- Wide Range Achievement Test-5(WRAT-5) score ≥ 85
- Ability to use mobile devices
- Fluent in English or Spanish
- Cannabis is used exclusively as prescribed or directed by their provider
- Meets DSM-V criteria for substance use disorder within the past six months for any psychoactive substance other than cannabis
- Meets DSM-V criteria for alcohol use disorder within the past six months
- Primary psychiatric disorder (major depressive disorder, bipolar disorder, or psychotic disorder) as the principal diagnosis, independent of cannabis use disorder; or current diagnosis of bipolar disorder, psychotic...
- Primary neurologic or major medical disorder that would interfere with study participation.
- Enrolled in group or individual therapy for substance use disorder that would be concurrent with the study intervention
- History of moderate or severe traumatic brain injury
- Seizure disorder or recent (\<5 years) seizure history
- Presence of metal or active implants in the head/neck
- Any skin disorder or skin sensitive area near stimulation locations
- Pregnant or planning pregnancy during the study period or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.